test

Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma

Conditions

Adult Rhabdomyosarcoma | Childhood Desmoplastic Small Round Cell Tumor | Chordoma | Desmoid Tumor | Metastatic Childhood Soft Tissue Sarcoma | Nonmetastatic Childhood Soft Tissue Sarcoma | Previously Treated Childhood Rhabdomyosarcoma | Previously Untreated Childhood Rhabdomyosarcoma | Recurrent Adult Soft Tissue Sarcoma | Recurrent Childhood Rhabdomyosarcoma | Recurrent Childhood Soft Tissue Sarcoma | Soft Tissue | Stage I Adult Soft Tissue Sarcoma | Stage II Adult Soft Tissue Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma

Trial Phase

Trial Purpose and Description

Trial Purpose

The purpose of this study is to collect and store tumor tissue, blood, and bone marrow samples from patients with soft tissue sarcoma that will be tested in the laboratory. Collecting and storing samples of tumor tissue, blood, and bone marrow from patients to test in the laboratory may help the study of cancer.


Participation Guidelines

Age:
Up to 50 Years
Gender:
Both

Eligibility Criteria


DISEASE CHARACTERISTICS:

  • Histologically or cytologically confirmed diagnosis of 1 of the following:
  • Rhabdomyosarcoma
  • Non-rhabdomyosarcoma soft tissue sarcoma
  • Chordoma
  • Desmoid fibromatosis
  • Desmoplastic round cell tumors
  • Undifferentiated embryonal sarcoma of the liver
  • Unclassified soft tissue sarcoma that is too undifferentiated to be placed in a specific pathologic category in the WHO classification (often called "undifferentiated soft tissue sarcoma" or "soft tissue sarcoma NOS")
  • Other soft tissue neoplasms, excluding benign tumors
  • Must have pathological specimens of tumor-containing tissue or bone marrow (beyond that needed by the institution for diagnosis) available for study
  • No malignant rhabdoid tumor, Ewing sarcoma/primitive neuroectodermal tumor, or osteogenic sarcoma of bone
  • No osteogenic sarcoma


PATIENT CHARACTERISTICS:

  • Not specified


PRIOR CONCURRENT THERAPY:

  • Not specified
Sponsor:
Children's Oncology Group (The)
 
National Cancer Institute (NCI)
Dates:
04/19/2000
Last Updated:
Study HIC#:
0004010978